Related Experiment Videos

Management of headshaking in three horses by treatment for protozoal myeloencephalitis

L A Moore1, P J Johnson, N T Messer

  • 1Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia 65211, USA.

The Veterinary Record
|October 8, 1997
PubMed

Insights

Equine protozoal myeloencephalitis (EPM) can cause headshaking in horses. This study found that a combination of potentiated sulphonamides and pyrimethamine effectively treated EPM-induced headshaking and associated behaviors.

Area of Science:

  • Veterinary neurology
  • Equine medicine
  • Parasitology

Background:

  • Headshaking is uncommon in horses in Missouri, unlike the rising incidence of equine protozoal myeloencephalitis (EPM).
  • EPM is a neurological disease affecting horses, caused by *Sarcocystis neurona* or *Neospora hughesi*.
  • Stereotypical behaviors can sometimes accompany neurological conditions in horses.

Purpose of the Study:

  • To investigate the potential role of EPM in horses presenting with headshaking.
  • To evaluate the efficacy of specific drug treatments for EPM-related headshaking.

Main Methods:

  • Neurological examination of affected horses.
  • Analysis of cerebrospinal fluid (CSF) to detect inflammation and/or protozoal presence.
  • Treatment trials using potentiated sulphonamides and pyrimethamine.

Main Results:

  • Equine protozoal myeloencephalitis was diagnosed in three horses examined for headshaking.
  • The headshaking and stereotypical behaviors observed in these horses were successfully resolved.
  • Treatment with potentiated sulphonamides and pyrimethamine proved effective.

Conclusions:

  • EPM should be considered in the differential diagnosis for horses exhibiting headshaking, especially in regions with increasing EPM incidence.
  • Potentiated sulphonamides and pyrimethamine offer a successful treatment strategy for EPM-induced headshaking and associated behaviors in horses.

Related Concept Videos